BioAtla Inc. (BCAB)
NASDAQ: BCAB
· Real-Time Price · USD
0.48
-0.03 (-5.46%)
At close: Jun 10, 2025, 3:59 PM
BioAtla Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.33M | -14.88M | -10.59M | -21.07M | -23.23M | -26.93M | -33.33M | -35.75M | -27.46M | -27.54M | -25.78M | -28.91M | -24.25M | -23.39M | -22.93M | -30.38M | -18.7M |
Depreciation & Amortization | 183K | 228K | 228K | 229K | 240K | 368K | 270K | 290K | 293K | 298K | 300K | 288K | 313K | 314K | 380K | 327K | 309K |
Stock-Based Compensation | 1.65M | 1.93M | 2.19M | 2.5M | 2.3M | 2.74M | 3.52M | 3.67M | 3.61M | 3.5M | 3.59M | 3.84M | 3.63M | 3.81M | 4.37M | 12.3M | 4.64M |
Other Working Capital | -3.02M | -3.25M | 2.39M | 1.1M | -1.16M | 1.14M | 235K | 269K | -2.25M | -2.31M | -422K | -433K | -2.39M | -4.18M | 1.13M | -1.34M | -1.31M |
Other Non-Cash Items | -1.88M | -807K | n/a | 4.9M | 11.76M | 10.72M | 29.81M | 32.08M | 1.05M | 7K | 5.89M | 6K | 6.69M | 221K | -107K | -55K | -56K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -10.72M | -29.81M | -32.08M | -1.05M | n/a | -5.89M | n/a | n/a | n/a | -690K | 4K | n/a |
Change in Working Capital | -902K | -3.25M | 3.03M | -846K | -10.13M | -6.11M | 2.19M | 7.69M | 899K | -610K | -2.13M | 7.85M | -4.83M | -1.9M | 6.25M | 4.26M | -1.19M |
Operating Cash Flow | -16.29M | -16.78M | -5.13M | -19.19M | -30.83M | -29.92M | -27.34M | -24.09M | -22.65M | -24.35M | -24.02M | -16.92M | -25.14M | -20.95M | -12.73M | -13.54M | -14.99M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -8K | -25K | -15K | -50K | -31K | -58K | -169K | -10K | -89K | -99K | -235K | -501K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.00 | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -8K | -25K | -15K | -50K | -31K | -58K | -166K | -10K | -89K | -99K | -235K | -501K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 13.00 | 244K | -13 | -30 | -55 | -58 | -116 | n/a | -96 | -70 | -405 | -3.91K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -395K | 9.31M | -14K | 225K | -13K | 119K | -41K | 115K | -116K | 83K | -96K | -51K | -405K | n/a | 330K | 190K | -1.91M |
Financial Cash Flow | -395K | 9.31M | -14K | 225K | -13K | 119.00 | -41 | 115.00 | -116 | 61.77K | -96 | -51 | -405 | -3.91M | 75.14M | 190K | -1.91M |
Net Cash Flow | -16.68M | -7.47M | -5.15M | -18.97M | -30.84M | -29.81M | -27.41M | -23.99M | -22.82M | 37.39M | -24.17M | -17.14M | -25.55M | -24.95M | 62.32M | -13.59M | -17.41M |
Free Cash Flow | -16.29M | -16.78M | -5.13M | -19.19M | -30.83M | -29.93M | -27.37M | -24.11M | -22.7M | -24.38M | -24.07M | -17.09M | -25.15M | -21.04M | -12.82M | -13.78M | -15.49M |